drugset / Trial / NCT03170310
Apatinib Treatment for Advanced Esophagus Cancer
NaSingle-groupOpen-labelTreatment
Summary
Subject ever received a standard chemotherapy solution progression or recurrence or can't tolerate chemotherapy with advanced esophageal squamous carcinoma.
Timeline
- Start
- 2017-02-21
- Primary completion
- 2019-02-21
- Completion
- 2019-09-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |